Anti-ATF6 antibody
5
(1 Review)
|
(2 Publications)
Goat Polyclonal ATF6 antibody. Suitable for ICC, WB and reacts with Human samples. Cited in 2 publications. Immunogen corresponding to Synthetic Peptide within Human ATF6 aa 400-450.
View Alternative Names
Cyclic AMP-dependent transcription factor ATF-6 alpha, cAMP-dependent transcription factor ATF-6 alpha, Activating transcription factor 6 alpha, ATF6-alpha, ATF6
- ICC
Supplier Data
Immunocytochemistry - Anti-ATF6 antibody (AB174756)
Immunocytochemistry analysis of paraformaldehyde fixed HeLa cells labelling ATF6 with ab174756 at 10 μg/mL. Cells permeabilized with 0.15% Triton. Primary incubation for 1 hour followed by Alexa Fluor® 488 secondary antibody (2 μg/mL). The nuclear stain is DAPI (blue).
Negative control : Unimmunized goat IgG (10 μg/mL) followed by Alexa Fluor® 488 secondary antibody (2 μg/mL).
- ICC
Supplier Data
Immunocytochemistry - Anti-ATF6 antibody (AB174756)
Immunocytochemistry analysis of paraformaldehyde fixed A431 cells labelling ATF6 with ab174756 at 10 μg/mL. Cells permeabilized with 0.15% Triton. Primary incubation for 1 hour followed by Alexa Fluor® 488 secondary antibody (2 μg/mL). The nuclear stain is DAPI (blue).
Negative control : Unimmunized goat IgG (10 μg/mL) followed by Alexa Fluor® 488 secondary antibody (2 μg/mL).
- WB
Supplier Data
Western blot - Anti-ATF6 antibody (AB174756)
All lanes:
Western blot - Anti-ATF6 antibody (ab174756) at 1 µg/mL
Lane 1:
HeLa whole cell lysate in RIPA buffer at 35 µg
Lane 2:
MCF7 whole cell lysate in RIPA buffer at 35 µg
Lane 3:
HeLa nuclear cell lysate in RIPA buffer at 35 µg
Lane 4:
Jurkat nuclear cell lysate in RIPA buffer at 35 µg
Predicted band size: 74 kDa
Observed band size: 75-80 kDa
true
Reactivity data
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
ATF6 operates as part of the transcription regulation mechanisms responding to ER stress. The ATF6 protein is essential in managing the expression of chaperone genes and ER-associated degradation (ERAD) components thereby maintaining protein homeostasis. ATF6 itself does not operate within a traditional complex but its activation involves proteolytic cleavage which subsequently releases the active form to the nucleus where it influences gene expression to alleviate stress conditions.
Pathways
ATF6 is prominently involved in the unfolded protein response pathway which manages cell survival and stress adaptation. This pathway closely interacts with other proteins like IRE1 and PERK forming a network that modulates the transcription of UPR target genes. Additionally ATF6 contributes to checkpoint control pathways that stabilize cellular environment by regulating genes related to chaperone and protein folding.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (2)
Recent publications for all applications. Explore the full list and refine your search
American journal of translational research 12:4354-4370 PubMed32913511
2020
Applications
Unspecified application
Species
Unspecified reactive species
Cancer medicine 8:6344-6357 PubMed31464090
2019
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com